Top

Systematic Reviews

Published in:

Open Access 01-12-2021 | Methoxyflurane | Protocol

Inhaled methoxyflurane (Penthrox) for analgesia in trauma: a systematic review protocol

Authors: Michael M. Eager, Grant S. Nolan, Kathryn Tonks, Anoopama Ramjeeawon, Natalie Taylor

Published in: Systematic Reviews | Issue 1/2021

Abstract

Background

More than 75% of patients presenting to the Emergency Department are suffering symptoms of pain. Despite this, 67% will not receive any analgesia. Methoxyflurane is a fluorinated hydrocarbon gas which has analgesic properties when inhaled. Penthrox is a methoxyflurane autoinhaler recently licenced in Europe. Its ease of administration, safety, and fast onset of action make it of particular relevance to emergency medicine. Additionally, outside the hospital, it has the advantage of increased temperature stability and portability over current standard care. New evidence of its efficacy is emerging; however, currently, its use in Europe is not widespread. The objective of this study will be to systematically evaluate the evidence on inhaled methoxyflurane to determine if it is a superior analgesia in the acute trauma setting.

Methods

We designed and registered a study protocol for a systematic review and meta-analysis on randomised controlled trials, comparing inhaled methoxyflurane and either placebo or standard care. A comprehensive search will be conducted from database inception onwards in MEDLINE, Embase, and the Cochrane CENTRAL database, concurrent with a search of the grey literature for other relevant studies, including clinical trial databases. Only randomised controlled trials will be included. No limitations will be imposed on publication status or language of publication. The primary outcome will be mean difference in patient-reported pain at time points within the first 30 min of administration. Secondary outcomes will be mean difference in time to clinically significant pain relief and relative risk of adverse effects. Two reviewers will independently screen all returned studies and collect data. Disagreements will be resolved through discussion or referral to a third reviewer. Individual study methodological quality will be appraised using an appropriate tool. If feasible, we will conduct a random effects meta-analysis; if this is not possible, we will construct a narrative synthesis.

Discussion

This systematic review will summarise the best available evidence and definitively establish if inhaled methoxyflurane is a superior analgesia to standard care in the acute trauma setting. This knowledge will directly impact emergency care in the UK and worldwide and may require amendments to European pain relief guidelines.

Systematic review registration

PROSPERO CRD42020189119.

Available only for authorised users

Porter KM, Dayan AD, Dickerson S, Middleton PM. The role of inhaled methoxyflurane in acute pain management. Open Access Emerg Med. 2018;10:149–64. https://doi.org/10.2147/OAEM.S181222.CrossRefPubMedPubMedCentral

Raja SN, Mazze RI. Methoxyflurane revisited: tale of an anesthetic from cradle to grave. Anethesiology. 2006;105:843–6.CrossRef

Dayan AD. Analgesic use of inhaled methoxyflurane. Hum Exp Toxicol. 2016;35(1):91–100. https://doi.org/10.1177/0960327115578743.CrossRefPubMed

Schug SA, Palmer GM, Scott DA, Halliwell R, Trinca J, eds. Acute pain management: scientific evidence. Fourth Edi. Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine; 2015. www.tga.gov.au

Introducing Penthrox® | Penthrox Europe – Methoxyflourane. Accessed June 1, 2020. https://www.penthrox.eu/intro/

Coffey F, Wright J, Hartshorn S. STOP!: a randomised, double-blind, placebo-controlled study of the efficacy and safety of methoxyflurane for the treatment of acute pain. Emerg Med J. Published online 2014. doi:https://doi.org/10.1136/emermed-2014-203690

Borobia AM, Collado SG, Cardona CC, et al. Inhaled methoxyflurane provides greater analgesia and faster onset of action versus standard analgesia in patients with trauma pain: InMEDIATE: a randomized controlled trial in emergency departments. Ann Emerg Med. 2020;75(3):315–28. https://doi.org/10.1016/j.annemergmed.2019.07.028.CrossRefPubMed

Mercadante S, Voza A, Serra S, et al. Analgesic efficacy, practicality and safety of inhaled methoxyflurane versus standard analgesic treatment for acute trauma pain in the emergency setting: a randomised, open-label, active-controlled, multicentre trial in Italy (MEDITA). Adv Ther. 2019;36(11):3030–46. https://doi.org/10.1007/s12325-019-01055-9.CrossRefPubMedPubMedCentral

Ricard-Hibon A, Lecoules N, Savary D, et al. Inhaled methoxyflurane for the management of trauma related pain in patients admitted to hospital emergency departments (PenASAP study). Eur J Emerg Med Published online April 2020:1. doi:https://doi.org/10.1097/mej.0000000000000686

10.

Forrest M, Porter K, van der Velde J. Methoxyflurane (Penthrox®)—a case series of use in the prehospital setting. J Paramedic Practice. 2019;11(2):54–60. https://doi.org/10.12968/jpar.2019.11.2.54.CrossRef

11.

Frangos J, Belbachir A, Dautheville S, et al. Non-interventional study evaluating exposure to inhaled, low-dose methoxyflurane experienced by hospital emergency department personnel in France. BMJ Open. 2020;10(2):e034647. https://doi.org/10.1136/bmjopen-2019-034647.CrossRefPubMedPubMedCentral

12.

Cisewski DH, Motov SM. Essential pharmacologic options for acute pain management in the emergency setting. Turk J Emerg Med. 2019;19(1):1–11. https://doi.org/10.1016/j.tjem.2018.11.003.CrossRefPubMed

13.

Dale J, Bjørnsen LP. Assessment of pain in a Norwegian Emergency Department. Scand J Trauma, Resusc Emerg Med. 2015;23(1):86. https://doi.org/10.1186/s13049-015-0166-3.CrossRef

14.

Mura P, Serra E, Marinangeli F, et al. Prospective study on prevalence, intensity, type, and therapy of acute pain in a second-level urban emergency department. J Pain Res. 2017;10:2781–8. https://doi.org/10.2147/JPR.S137992.CrossRefPubMedPubMedCentral

15.

Cohen HML, Wolstenholme R. Penthrox: a breath of PHEC air for the military? J R Army Med Corps Month. 2019;0(0). https://doi.org/10.1136/jramc-2018-001122.

16.

Montassier E, Freund Y. A rigorous evaluation of methoxyflurane is needed: comment on “Methoxyflurane versus standard of care for acute trauma-related pain in the emergency setting: protocol for a randomised, controlled study in Italy (MEDITA)”. Adv Ther. 2019;36(6):1241. https://doi.org/10.1007/s12325-019-00936-3.CrossRefPubMedPubMedCentral

17.

J v M, Mrcsed JM. Is methoxyflurane a suitable battlefield analgesic? JR Army Med Corps. 153(2):111–3. https://doi.org/10.1136/jramc-153-02-08.

18.

Griffiths E. Efficacy and safety of methoxyflurane: managing trauma associated pain in UK SAR helicopter paramedic practice. J Paramedic Pract. 2017;2;9(3):108-20.

19.

Bijur PE, Kenny MK, Gallagher EJ. Intravenous morphine at 0.1 mg/kg is not effective for controlling severe acute pain in the majority of patients. Ann Emerg Med. 2005;46(4):362–7. https://doi.org/10.1016/j.annemergmed.2005.03.010.CrossRefPubMed

20.

Porter KM, Siddiqui MK, Sharma I, Dickerson S, Eberhardt A. Management of trauma pain in the emergency setting: low-dose methoxyflurane or nitrous oxide? A systematic review and indirect treatment comparison. J Pain Res. 2018;11:11–21. https://doi.org/10.2147/JPR.S150600.CrossRefPubMed

21.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1-9.

22.

Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions . https://training.cochrane.org/handbook

23.

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Online). 2009;339(7716):332–6. https://doi.org/10.1136/bmj.b2535.CrossRef

24.

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1). https://doi.org/10.1186/s13643-016-0384-4.

25.

Methoxyflurane | Drug | BNF content published by NICE. Accessed June 17, 2020. https://bnf.nice.org.uk/drug/methoxyflurane.html

26.

Young T, Hopewell S. Methods for obtaining unpublished data. Cochrane Database Syst Rev. 2011;11. https://doi.org/10.1002/14651858.mr000027.pub2.

27.

Abell B, Glasziou P, Hoffmann T. Reporting and replicating trials of exercise-based cardiac rehabilitation: do we know what the researchers actually did? Circ Cardiovasc Qual Outcomes. 2015;8(2):187–94. https://doi.org/10.1161/CIRCOUTCOMES.114.001381.CrossRefPubMed

28.

Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. The BMJ. 2019;366. https://doi.org/10.1136/bmj.l4898.

29.

Review Manager Web (RevMan Web). Published online 2019. revman.cochrane.org

30.

Guyatt GH, Oxman AD, Vist GE, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6. https://doi.org/10.1136/bmj.39489.470347.ad.CrossRefPubMedPubMedCentral

31.

Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. The BMJ. 2020;368. https://doi.org/10.1136/bmj.l6890.

32.

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.CrossRefPubMedPubMedCentral

33.

Olsen MF, Bjerre E, Hansen MD, et al. Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain. BMC Medicine. 2017;15(1):35. https://doi.org/10.1186/s12916-016-0775-3.CrossRefPubMedPubMedCentral

34.

Montassier E, Freund Y. Guidelines for letters to the editor methoxyflurane may provide faster relief than suboptimal treatment, but not better. Ann Emerg Med. 2020;75:550–1. https://doi.org/10.1016/j.annemergmed.2019.12.007.CrossRefPubMed

35.

Grindlay J, Babl FE. Review article: efficacy and safety of methoxyflurane analgesia in the emergency department and prehospital setting. Emerg Med Australas. 2009;21(1):4–11. https://doi.org/10.1111/j.1742-6723.2009.01153.x.CrossRefPubMed

36.

Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017;2:MR000033. https://doi.org/10.1002/14651858.MR000033.pub3.CrossRefPubMed

Title: Inhaled methoxyflurane (Penthrox) for analgesia in trauma: a systematic review protocol
Authors: Michael M. Eager
Grant S. Nolan
Kathryn Tonks
Anoopama Ramjeeawon
Natalie Taylor
Publication date: 01-12-2021
Publisher: BioMed Central
Keyword: Methoxyflurane
Published in: Systematic Reviews / Issue 1/2021
Electronic ISSN: 2046-4053
DOI: https://doi.org/10.1186/s13643-021-01600-0

At a glance: The STEP trials

Springer Medicine

Inhaled methoxyflurane (Penthrox) for analgesia in trauma: a systematic review protocol

Abstract

Background

Methods

Discussion

Systematic review registration

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Discussion

Systematic review registration

Please log in to get access to this content

Other articles of this Issue 1/2021

A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance

Community-based educational interventions for prevention of type II diabetes: a global systematic review and meta-analysis

Interventions directed at men for preventing intimate partner violence: a systematic review protocol

Screening for depression in children and adolescents: a protocol for a systematic review update

Effects of home visits on quality of life among older adults: a systematic review protocol

Screening for chlamydia and/or gonorrhea in primary health care: systematic reviews on effectiveness and patient preferences